3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
18
Neoplasm Metastasis
6
Urogenital Neoplasms
1
Unilateral Breast Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
HR+/HER2- Breast Cancer
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Breast Cancer Female
1
Advanced Breast Cancer
1
Interventions
ribociclib
1
palbociclib
1
exemestane
1
abemaciclib
1
Letrozole
1
Fulvestrant
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unilateral Breast Neoplasms
×
abemaciclib
×
Clear all
NCT06760637
2026-05-19
FourLight-3
Pfizer
Phase 3
Active not recruiting
1,035 enrolled